The Effect of Virtual Reality and Eye Mask During Dressing After CABG Surgery
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jun 25, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using virtual reality (VR) or an eye mask (EM) can help reduce pain and anxiety during dressing changes after heart bypass surgery (known as CABG). After this surgery, changing the dressings on the chest can be painful and stressful, which may slow down recovery and increase the need for pain medicines. The study wants to see if VR or an eye mask can make this experience more comfortable without using extra drugs.
Adults between 18 and 65 years old who are having their first CABG surgery and are awake, alert, and able to communicate may be eligible to join. Participants will be randomly placed into one of three groups: one using VR, one using an eye mask, or one receiving usual care. During and after the dressing changes, their pain, anxiety, and vital signs (like heart rate and blood pressure) will be measured. The study is taking place in a hospital intensive care unit in Istanbul, Türkiye. If successful, this approach could offer a simple and low-cost way to improve comfort and reduce stress after heart surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18-65 years
- • First-time coronary artery bypass graft (CABG) surgery for coronary artery disease
- • ASA physical status I, II, or III
- • Conscious, oriented, and cooperative
- • Able to communicate verbally
- • Provided written informed consent
- Exclusion Criteria:
- • Presence of sternal wound infection or inflammation
- • Intubated at the time of assessment
- • Undergoing revision surgery
- • Receiving anesthesia or sedation in the ICU
- • Experiencing intraoperative or postoperative complications
- • Inability to speak Turkish
- • Hearing or visual impairment
- • Diagnosed psychiatric or cognitive disorder
- • Diagnosis of epilepsy
- • Body mass index (BMI) ≥ 30
- • Participation in another clinical trial during the same period
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Marmara, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported